Free Trial

Scholar Rock (NASDAQ:SRRK) Trading Down 5.2%

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)

Scholar Rock Holding Co. (NASDAQ:SRRK - Get Free Report)'s stock price was down 5.2% during mid-day trading on Tuesday . The stock traded as low as $13.96 and last traded at $14.27. Approximately 129,190 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 763,442 shares. The stock had previously closed at $15.06.

Wall Street Analyst Weigh In

Several research analysts have issued reports on SRRK shares. Raymond James started coverage on Scholar Rock in a research report on Thursday, March 28th. They issued a "strong-buy" rating and a $30.00 target price on the stock. HC Wainwright reissued a "buy" rating and issued a $30.00 target price on shares of Scholar Rock in a research report on Tuesday, March 19th. Piper Sandler reaffirmed an "overweight" rating and set a $28.00 price objective on shares of Scholar Rock in a research report on Tuesday, March 26th. Wedbush reaffirmed an "outperform" rating and set a $23.00 price objective on shares of Scholar Rock in a research report on Tuesday. Finally, Truist Financial reaffirmed a "buy" rating and set a $20.00 price objective on shares of Scholar Rock in a research report on Wednesday, April 3rd. Five analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $25.17.

Get Our Latest Analysis on Scholar Rock

Scholar Rock Trading Down 2.5 %


The stock has a fifty day moving average of $15.24 and a 200 day moving average of $14.90. The company has a debt-to-equity ratio of 0.22, a quick ratio of 8.80 and a current ratio of 8.80. The company has a market capitalization of $1.17 billion, a PE ratio of -7.16 and a beta of 0.94.

Scholar Rock (NASDAQ:SRRK - Get Free Report) last posted its quarterly earnings results on Tuesday, March 19th. The company reported ($0.50) EPS for the quarter, missing analysts' consensus estimates of ($0.49) by ($0.01). As a group, sell-side analysts predict that Scholar Rock Holding Co. will post -2.01 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, General Counsel Junlin Ho sold 3,489 shares of the business's stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $15.74, for a total value of $54,916.86. Following the transaction, the general counsel now directly owns 208,771 shares of the company's stock, valued at approximately $3,286,055.54. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Scholar Rock news, General Counsel Junlin Ho sold 3,489 shares of Scholar Rock stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $15.74, for a total value of $54,916.86. Following the sale, the general counsel now owns 208,771 shares of the company's stock, valued at approximately $3,286,055.54. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Jay T. Backstrom sold 11,614 shares of Scholar Rock stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $15.74, for a total value of $182,804.36. Following the completion of the sale, the chief executive officer now directly owns 352,671 shares in the company, valued at approximately $5,551,041.54. The disclosure for this sale can be found here. In the last three months, insiders have sold 22,359 shares of company stock valued at $351,931. Corporate insiders own 26.20% of the company's stock.

Institutional Trading of Scholar Rock

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Susquehanna Fundamental Investments LLC bought a new position in shares of Scholar Rock during the 1st quarter worth $945,000. Jennison Associates LLC grew its position in shares of Scholar Rock by 1.0% during the 1st quarter. Jennison Associates LLC now owns 138,458 shares of the company's stock worth $2,459,000 after buying an additional 1,409 shares in the last quarter. Capstone Investment Advisors LLC bought a new position in shares of Scholar Rock during the 1st quarter worth $383,000. China Universal Asset Management Co. Ltd. grew its position in shares of Scholar Rock by 66.2% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 13,868 shares of the company's stock worth $246,000 after buying an additional 5,522 shares in the last quarter. Finally, Wellington Management Group LLP bought a new position in shares of Scholar Rock during the 4th quarter worth $1,347,000. Hedge funds and other institutional investors own 91.08% of the company's stock.

About Scholar Rock

(Get Free Report)

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ The only AI company to buy (From Porter & Company) (Ad)

Should you invest $1,000 in Scholar Rock right now?

Before you consider Scholar Rock, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scholar Rock wasn't on the list.

While Scholar Rock currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: